Open access · CC-BY
via OpenAlex
Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
Javier Donate‐Correa, Ernesto Martín‐Núñez, Carmen Mora Fernández, Ainhoa González-Luis, Alberto Martín-Olivera, Juan F. Navarro‐González
International Journal of Molecular Sciences · 2023 · ▲ 15 citations
Abstract
Abstract Aims A significant reduction in circulating Klotho levels is observed in subjects with type 2 diabetes mellitus (T2DM). In this work, we examined the relationship between Klotho levels and coronary artery disease (CAD) burden in subjects with T2DM and preserved kidney function. Methods Cross-sectional case-control study involving 133 subjects with T2DM and 200 age-, sex- and CAD incidence-matched, non-diabetic patients undergoing nonemergency diagnostic coronary angiography. All of them non-albuminuric and with normal glomerular filtration rates. Concentrations of serum Klotho, fibroblast growth factor 23, and inflammatory markers were also measured. Results The Klotho concentration was lower in the group with DM2 although higher in the subgroup of subjects with DM2 and significant CAD (45.6%; P=0.02). Multiple regression analysis revealed that serum Klotho was positively related with SSI values exclusively in subjects with T2DM (adjusted R2=0.153, P<0.01). Logistic regression analysis showed that Klotho was positively associated with the presence of significant CAD in the group of T2DM patients (OR: 1.001; P=0.041). Conclusions Our data suggest that higher levels of circulating Klotho in subjects with T2DM and preserved kidney function are associated with significant CAD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms241713456
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Donate‐Correa, J., Martín‐Núñez, E., Fernández, C.M., González-Luis, A., Martín-Olivera, A., & Navarro‐González, J.F. (2023). Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms241713456
Vancouver
Donate‐Correa J, Martín‐Núñez E, Fernández CM, González-Luis A, Martín-Olivera A, Navarro‐González JF. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713456.
BibTeX
@article{javier2023Associ,
title = {Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study},
author = {Javier Donate‐Correa and Ernesto Martín‐Núñez and Carmen Mora Fernández and Ainhoa González-Luis and Alberto Martín-Olivera and Juan F. Navarro‐González},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241713456},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Advancements in Life Sciences 2025
Open access · CC-BY
Assessment of Protein Klotho as Monitor in Diabetic Nephropathy
BMC Nephrology 2019
Open access · CC-BY
Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study
Medical Bulletin of Haseki 2026
Open access · CC-BY
Association of Circulating FGF-23 and Klotho with Cardiovascular Disease in Patients with Chronic Kidney Disease
Journal of clinical medicine 2026
Open access · OA
Association of Homocysteine with Arterial Stiffness and Kidney Injury Biomarkers in Patients with Suspected Coronary Artery Disease.
Cell & Bioscience 2024
Open access · CC-BY
Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism
Scientific Reports 2021
Open access · CC-BY